May 16, 2013 - 8:20 pm
Faced with a decision on my treatment options, I first started leaning toward CyberKnife radiation. Then the more I read about the low risk category, Active Surveillance sounded right for me. Now the new Agent Orange study mentioned in another post here is saying that the type of prostate cancer caused by AO is more aggressive than "normal" prostate cancer. As there is no way of knowing for sure whether my cancer is AO-related, I am left wondering: am I really at low risk with my 3+3=6 Gleason score, PSA 4.7, 5% of one core? I've just read about the Genomic DX test which supposedly can better determine if my prostate cancer is low risk or high risk. Medicare probably doesn't pay for it so I would have to pay for it myself. I saw a price of $4,000 somewhere online. Now that's a lot of money to come out of my pocket, but if the test can tell me for sure that my cancer is low risk I would feel comfortable following AS. If it came back as high risk I would then decide to go with CyberKnife. So the money would be worth it if the test is reliable. Anybody have any experience with this test or know if it's indeed accurate?